OVERWEIGHT
Clinical trials for OVERWEIGHT explained in plain language.
Never miss a new study
Get alerted when new OVERWEIGHT trials appear
Sign up with your email to follow new studies for OVERWEIGHT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New diabetes and Weight-Loss drug tested in indian adults
Disease control Not yet recruitingThis study aims to check the safety and effectiveness of the medication tirzepatide for adults in India who have type 2 diabetes or who are overweight or have obesity. About 344 participants will receive the drug for 46 weeks. Researchers will monitor side effects and measure cha…
Matched conditions: OVERWEIGHT
Phase: PHASE4 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Apr 04, 2026 01:51 UTC
-
Can a spoonful of olive oil a day keep liver fat away?
Disease control Not yet recruitingThis study aims to see if adding extra virgin olive oil to a Mediterranean diet can help people with fatty liver disease (MASLD). Researchers will enroll 60 overweight adults and give them different daily amounts of olive oil for about 2.5 months. They will measure changes in liv…
Matched conditions: OVERWEIGHT
Phase: NA • Sponsor: Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis • Aim: Disease control
Last updated Apr 04, 2026 01:51 UTC
-
Could hydrogen water be the secret to shedding pounds?
Disease control Not yet recruitingThis study is testing whether drinking water with extra hydrogen dissolved in it helps overweight adults manage their weight and improve metabolic health. Researchers will compare hydrogen-rich water against regular water in 120 participants across multiple clinics. The goal is t…
Matched conditions: OVERWEIGHT
Phase: NA • Sponsor: Center for Health Sciences, Serbia • Aim: Disease control
Last updated Apr 04, 2026 01:51 UTC
-
Scientists test new weight loss shot combo
Disease control Not yet recruitingThis study is testing the safety and side effects of combining two new injectable medicines for weight management in people with overweight or obesity. About 100 participants will receive either the two-drug combination or one drug plus a placebo for comparison. The main goal is …
Matched conditions: OVERWEIGHT
Phase: PHASE1 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New drug injection aims to help shed pounds in early safety trial
Disease control Not yet recruitingThis is an early-stage study to test the safety and effects of a new injectable drug called brenipatide in healthy adults who are overweight or have obesity. Researchers will give different doses to about 150 participants to see how the body handles the drug and if it helps reduc…
Matched conditions: OVERWEIGHT
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New app aims to protect new Moms' hearts after dangerous pregnancy condition
Disease control Not yet recruitingThis study is testing a 9-month support program to help new mothers improve their heart health after a first pregnancy complicated by preeclampsia. The program uses a special smartphone app for tracking blood pressure and weight, along with online coaching and group meetings. Res…
Matched conditions: OVERWEIGHT
Phase: NA • Sponsor: Karolinska Institutet • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Stanford tests four digital diet tricks to beat obesity
Disease control Not yet recruitingThis study aims to find the most effective combination of four dietary strategies for weight loss in a fully digital program. Researchers will enroll 208 U.S. adults with overweight or obesity in a 12-week remote program testing different approaches to eating. The goal is to iden…
Matched conditions: OVERWEIGHT
Phase: NA • Sponsor: Stanford University • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New weight loss shot tested in major trial
Disease control Not yet recruitingThis study aims to see if two different injection devices for the weight loss medication CagriSema work the same way. About 1,400 adults with overweight or obesity will be randomly assigned to receive either the medication or a placebo for about one year. The main goal is to comp…
Matched conditions: OVERWEIGHT
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New weekly shot aims to outperform leading Weight-Loss drug
Disease control Not yet recruitingThis study aims to see if a new weekly injection called NNC0487-0111 is safe and works better than the approved drug semaglutide for people with both excess weight and type 2 diabetes. About 1,000 adults will be randomly assigned to receive either the new drug or semaglutide, bot…
Matched conditions: OVERWEIGHT
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Can you exercise for health, not guilt? new study aims to find out
Disease control Not yet recruitingThis small pilot study is testing a new group program designed to help people with obesity or overweight increase their physical activity in a healthy way. The main goal is to see if the program helps people exercise more without developing unhealthy relationships with food or ex…
Matched conditions: OVERWEIGHT
Phase: NA • Sponsor: Dartmouth-Hitchcock Medical Center • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
New shot for weight loss enters human testing
Disease control Not yet recruitingThis is a very early safety study for a new injection called SHR-2906, which is being developed to help with obesity. The main goal is to see if the drug is safe and how the body processes it. The study will first test single doses in healthy volunteers, then test multiple doses …
Matched conditions: OVERWEIGHT
Phase: PHASE1 • Sponsor: Beijing Suncadia Pharmaceuticals Co., Ltd • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
First human test for new Weight-Loss injection begins
Disease control Not yet recruitingThis is the first study to give the experimental drug SA030 to people. Researchers want to see if a single injection is safe and how the body handles it in 40 healthy adults who are overweight or obese. The main goal is to check for side effects and understand how the drug moves …
Matched conditions: OVERWEIGHT
Phase: PHASE1 • Sponsor: Suzhou Siran Biotechnology Co.,Ltd. • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
VA launches new push to support women Veterans' health
Disease control Not yet recruitingThis VA program aims to help clinics better provide proven health services for women Veterans in midlife. It will test two different support strategies across at least 18 VA facilities to help them offer trauma-informed care, menopause symptom therapy, and weight management progr…
Matched conditions: OVERWEIGHT
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Mar 13, 2026 15:06 UTC